Articles from Business Wire

Dream Finders Homes Releases 2023 Annual Shareholder Letter
Dream Finders Homes, Inc. (the “Company” or “DFH”) (NYSE: DFH), announced today the release of its 2023 Annual Shareholder Letter authored by Founder, CEO, and Chairman of Dream Finders Homes, Patrick Zalupski. To view the letter please visit investors.dreamfindershomes.com.
By Dream Finders Homes, Inc. · Via Business Wire · December 14, 2024
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo Holdings”), a global life sciences investment firm, today announced that the companies have fulfilled all regulatory closing conditions for their pending transaction. The companies now expect to close the transaction in the coming days.
By Catalent, Inc. · Via Business Wire · December 14, 2024
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Xiao-I Corporation (AIXI)
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 16, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of Xiao-I Corporation (“Xiao-I” or the “Company”) (NASDAQ: AIXI) investors who purchased: (a) American depository shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s March 2023 initial public offering (the “IPO” or “Offering”); and/or (b) securities between March 9, 2023 and July 12, 2024, both dates inclusive (the “Class Period”).
By Law Offices of Frank R. Cruz · Via Business Wire · December 13, 2024
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Healthcare Company Inc. (ACHC)
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 16, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Acadia Healthcare Company Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) securities between February 28, 2020 and October 30, 2024, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · December 13, 2024
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against WM Technology, Inc. (MAPS)
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 16, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired WM Technology, Inc. (“WM Technology” or the “Company”) (NASDAQ: MAPS) securities between May 25, 2021, and September 24, 2024, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · December 13, 2024
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Behalf of Customers Bancorp, Inc. (CUBI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 31, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSE: CUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).
By Glancy Prongay & Murray LLP · Via Business Wire · December 13, 2024
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Five9, Inc. (FIVN) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Five9, Inc. (“Five9” or the “Company”) (NASDAQ: FIVN) securities between June 4, 2024 and August 8, 2024, inclusive (the “Class Period”). Five9 investors have until February 3, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · December 13, 2024
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aehr Test Systems, Inc. (AEHR)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQ: AEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”).
By Glancy Prongay & Murray LLP · Via Business Wire · December 13, 2024
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ: KYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”). Kyverna investors have until February 7, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · December 13, 2024
Investor Alert: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Enphase Energy, Inc. and Encourages Investors With Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQ: ENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock between April 25, 2023, and October 22, 2024, inclusive (the “Class Period”). This action, captioned The Trustees of the Welfare and Pension Funds of Local 464A - Pension Fund v. Enphase Energy, Inc., et al., Case No. 3:24-cv-09038, was filed in the United States District Court for the Northern District of California.
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · December 13, 2024
Media Advisory: UnitedHealth Group Responds to Misinformation
UnitedHealth Group today issued the following update:
By UnitedHealth Group · Via Business Wire · December 13, 2024
OFS Credit Company Provides November 2024 Net Asset Value Update
OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced the following net asset value (“NAV”) estimate as of November 30, 2024.
By OFS Credit Company, Inc. · Via Business Wire · December 13, 2024
King County Launches Campaign to Prioritize Traffic Safety During the Holidays
This holiday season, agencies across Washington are mobilizing extra resources to keep roadways safe during one of the busiest travel times of the year. These efforts are part of the Night of 1,000 Stars campaign, which recognizes and remembers the dedicated traffic enforcement personnel who sacrifice time with loved ones during the holidays.
By King County Target Zero Coalition · Via Business Wire · December 13, 2024
Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced plans to host a conference call and webcast to report topline data for the THRIVE-2 phase 3 clinical trial, evaluating veligrotug in chronic TED, on Monday, December 16, 2024 at 8:00am ET.
By Viridian Therapeutics, Inc. · Via Business Wire · December 13, 2024
ACADIA HEALTHCARE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Acadia Healthcare Company, Inc. - ACHC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead plaintiff applications in securities class action lawsuits against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company’s securities between February 8, 2020 and October 30, 2024, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Middle District of Tennessee.
By Kahn Swick & Foti, LLC · Via Business Wire · December 13, 2024
Digi International Announces the Nomination of Two Accomplished Executives to its Board of Directors and the Pending Retirement of Sally Smith from the Board of Directors
Digi International (Nasdaq: DGII, www.digi.com), a leading global provider of Internet of Things (IoT) connectivity products and services, announces the nomination of two new members to its Board of Directors: Valerie Heusinkveld and Allison West Hughes. In addition, Sally Smith, a Digi director since 2018, has announced her intention to retire from the Board at the conclusion of the company’s annual meeting to be held on February 3, 2025. The election of Ms. Heusinkveld and Ms. Hughes will be voted on by the company’s stockholders at that same annual meeting.
By Digi International · Via Business Wire · December 13, 2024
Fairholme Funds, Inc. December 2024 Dividend Distributions
FAIRHOLME FUNDS, INC.
By Fairholme Funds, Inc. · Via Business Wire · December 13, 2024
Douglas Emmett Declares Quarterly Cash Dividend
Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today that its Board of Directors has declared a quarterly cash dividend on each share of its common stock of $0.19, or $0.76 on an annualized basis, to be paid on January 15, 2025 to shareholders of record as of December 31, 2024.
By Douglas Emmett, Inc. · Via Business Wire · December 13, 2024
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies. This follows the recent U.S. FDA approval of Nemluvio for subcutaneous injection for the treatment of adults with prurigo nodularis in August 2024.12
By Galderma · Via Business Wire · December 13, 2024
General American Investors Announces Issue Price for the 2024 Year-End Dividend and Distribution Payable on December 27, 2024
General American Investors Company, Inc. (NYSE: GAM), a closed-end investment company, announced that the price at which shares of its common stock will be issued to stockholders who elected to receive additional shares in payment of the 2024 year-end dividend and distribution on its common stock will be $52.26 per share. The issue price represents the average between the high and the low prices on the New York Stock Exchange on December 13, 2024, which was below the net asset value of $59.51 per share on that date. The dividend and distribution is payable on December 27, 2024. As announced on November 6, the dividend and distribution amounts to $4.50 per share in the aggregate and is estimated to consist of:
DR Horton Acquires Additional Land to Grow Booming Subdivision, Silverado
Davidson Bogel Real Estate (“DB2RE”) is pleased to announce an additional phase to DR Horton’s master-planned community, Silverado. The homebuilder purchased 32 adjacent acres for an additional phase.
By Davidson Bogel Real Estate · Via Business Wire · December 13, 2024
Alliance Resource Partners, L.P. Announces McDaniel Elected to Alliance Board
Alliance Resource Partners, L.P. (NASDAQ: ARLP) ("ARLP") today announced that Ronna R. McDaniel has been appointed to the Board of Directors of Alliance Resource Management GP, LLC (the “MGP”), the general partner of ARLP, effective December 11, 2024. Ms. McDaniel will also serve as a member of the Audit, Compensation and Conflicts Committees of the Board of Directors. The Board of Directors will be comprised of seven directors through the balance of 2024 and will be comprised of six directors starting January 1, 2025 on account of the previously announced retirement on December 31, 2024 of long-time director John Robinson.
By Alliance Resource Partners, L.P. · Via Business Wire · December 13, 2024
U.S. Sen. Tom Carper Honored at $3.52 Million Grant Announcement Ceremony
U.S. Sen. Tom Carper (D-DE) was recognized for his support of housing and community development during a ceremony today announcing $3.52 million in 2024 Affordable Housing Program (AHP) grant and the voluntary housing grant initiative awards. These awards from the Federal Home Loan Bank of Pittsburgh (FHLBank) are through member financial institutions.
By FHLBank Pittsburgh · Via Business Wire · December 13, 2024
API Icons Prabal Gurung, Hiroyuki Sanada and More to be Honored at 22nd Annual Unforgettable Gala, as Next Generation of AAPI Recording Artists Added to All-Star Lineup with Thuy, Weston Estate, Party Foul, More
GoldenTV and Character Media proudly announce its full list of honorees and performers for the Dec. 14 Unforgettable Gala end-of-year celebration at the Beverly Hilton. Visionary fashion designer Prabal Gurung will receive the inaugural Cultural Icon award, and legendary actor Hiroyuki Sanada, star of Shōgun, is the inaugural Global Icon honoree. The 22nd Annual Unforgettable Gala is co-hosted by Stephanie Hsu (Everything Everywhere All At Once), Maitreyi Ramakrishnan (Never Have I Ever), and comedian JR De Guzman (The Comedy Lineup).
By GoldenTV · Via Business Wire · December 13, 2024
Krispy Kreme Declares Quarterly Dividend
Krispy Kreme, Inc. (NASDAQ:DNUT) (“Krispy Kreme” or the “Company”), today announced a quarterly cash dividend of $0.035 per share of common stock, in accordance with the Company’s dividend policy. The dividend was declared today, December 13, 2024, and will be paid on February 5, 2025 to shareholders of record on January 22, 2025.
By Krispy Kreme, Inc. · Via Business Wire · December 13, 2024